Abstract:Objective: Vascular smooth muscle cells (VSMCs) undergo the phenotypic changes from contractile to synthetic state during vascular remodeling after ischemia. SIRT1 protects against stress-induced vascular remodeling via maintaining VSMC differentiated phenotype. However, the effect of smooth muscle SIRT1 on the functions of endothelial cells (ECs) has not been well clarified. Here, we explored the role of smooth muscle SIRT1 in endothelial angiogenesis after ischemia and the underlying mechanisms.Methods: We performed a femoral artery ligation model using VSMC specific human SIRT1 transgenic (SIRT1-Tg) and knockout (KO) mice. Angiogenesis was assessed in in vivo by quantification of the total number of capillaries, wound healing and matrigel plug assays, and in vitro ECs by tube formation, proliferation and migration assays. The interaction of HIF1α with circRNA was examined by using RNA immunoprecipitation, RNA pull-down and in situ hybridization assays.Results: The blood flow recovery was significantly attenuated in SIRT1-Tg mice, and markedly improved in SIRT1-Tg mice treated with SIRT1 inhibitor EX527 and in SIRT1-KO mice. The density of capillaries significantly decreased in the ischemic gastrocnemius of SIRT1-Tg mice compared with SIRT1-KO and WT mice, with reduced expression of VEGFA, which resulted in decreased number of arterioles. We identified that the phenotypic switching of SIRT1-Tg VSMCs was attenuated in response to hypoxia, with high levels of contractile proteins and reduced expression of the synthetic markers and NG2, compared with SIRT1-KO and WT VSMCs. Mechanistically, SIRT1-Tg VSMCs inhibited endothelial angiogenic activity induced by hypoxia via the exosome cZFP609. The cZFP609 was delivered into ECs, and detained HIF1α in the cytoplasm via its interaction with HIF1α, thereby inhibiting VEGFA expression and endothelial angiogenic functions. Meantime, the high cZFP609 expression was observed in the plasma of the patients with atherosclerotic or diabetic lower extremity peripheral artery disease, associated with reduced ankle-brachial index. Knockdown of cZFP609 improved blood flow recovery after hindlimb ischemia in SIRT1-Tg mice.Conclusions: Our findings demonstrate that SIRT1 may impair the plasticity of VSMCs. cZFP609 mediates VSMCs to reprogram endothelial functions, and serves as a valuable indicator to assess the prognosis and clinical outcomes of ischemic diseases.

Circ-ATL1 silencing reverses the activation effects of SIRT5 on smooth muscle cellular proliferation, migration and contractility in intracranial aneurysm by adsorbing miR-455

Cyclic RNA hsa‑circ‑000595 regulates apoptosis of aortic smooth muscle cells

[Autophagy Regulates the Function of Vascular Smooth Muscle Cells in the Formation and Rupture of Intracranial Aneurysms].

Regulation of smooth muscle contractility by competing endogenous mRNAs in intracranial aneurysms.

LncRNA ANRIL Facilitates Vascular Smooth Muscle Cell Proliferation and Suppresses Apoptosis via Modulation of miR-7/FGF2 Pathway in Intracranial Aneurysms

Activation of BMP4-pSmad1/5 Pathway Impairs the Function of VSMCs in Intracranial Aneurysms.

WNTA5-mediated miR-374a-5p regulates vascular smooth muscle cell phenotype transformation and M1 macrophage polarization impacting intracranial aneurysm progression

Circular RNA circLIFR regulates the proliferation, migration, invasion and apoptosis of human vascular smooth muscle cells via the miR-1299/KDR axis

Decreased Expression of Circ_0020397 in Intracranial Aneurysms May Be Contributing to Decreased Vascular Smooth Muscle Cell Proliferation Via Increased Expression of Mir-138 and Subsequent Decreased KDR Expression

miR‐4735‐3p regulates phenotypic modulation of vascular smooth muscle cells by targeting HIF‐1‐mediated autophagy in intracranial aneurysm

Circdiaph3 Regulates Rat Vascular Smooth Muscle Cell Differentiation, Proliferation, and Migration

SLC44A2 Regulates Vascular Smooth Muscle Cell Phenotypic Switching and Aortic Aneurysm

Circ_0022920 Maintains the Contractile Phenotype of Human Aortic Vascular Smooth Muscle Cells Via Sponging microRNA-650 and Promoting Transforming Growth Factor Beta Receptor 1 Expression in Angiotensin II-Induced Models for Aortic Dissection.

Mir-144-3p Regulates Vascular Smooth Muscle Cell Phenotypic Switch Via FBN1

Inflammatory Smooth Muscle Cells Induce Endothelial Cell Alterations to Influence Cerebral Aneurysm Progression via Regulation of Integrin and VEGF Expression

Mir-139-5p Suppresses Proliferation and Angiogenesis of Intracranial Aneurysm Via FGB

Smooth muscle SIRT1 reprograms endothelial cells to suppress angiogenesis after ischemia

LTBP2 down-regulated FGF2 to repress vascular smooth muscle cell proliferation and vascular remodeling in a rat model of intracranial aneurysm

Hsa-Mir-15b-5p Regulates the Proliferation and Apoptosis of Human Vascular Smooth Muscle Cells by Targeting the ACSS2/PTGS2 Axis

CircCBFB-mediated Mir-28-5p Facilitates Abdominal Aortic Aneurysm Via LYPD3 and GRIA4.

RelB Represses Mir-193A-5p Expression to Promote the Phenotypic Transformation of Vascular Smooth Muscle Cells in Aortic Aneurysm